{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T21:52:44Z","timestamp":1723326764454},"reference-count":25,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.intimp.2009.04.009","type":"journal-article","created":{"date-parts":[[2009,4,23]],"date-time":"2009-04-23T08:58:16Z","timestamp":1240477096000},"page":"1010-1015","source":"Crossref","is-referenced-by-count":1,"title":["Tuberculin sensitivity and morphological immune response in guinea pigs after application of minimal sensitizing dose of BCG vaccine, substrain Sofia SL222"],"prefix":"10.1016","volume":"9","author":[{"given":"M.","family":"Bachvarova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Stefanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nikolaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chouchkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2009.04.009_bib1","first-page":"686","article-title":"Bronchial lymphoid tissues: morphologic characteristics","volume":"28","author":"Bienestock","year":"1973","journal-title":"Lab Invest"},{"key":"10.1016\/j.intimp.2009.04.009_bib2","series-title":"Tuberculosis: pathogenesis, protection, and control","first-page":"531","article-title":"The BCG experience: implications for future vaccines against tuberculosis","author":"Bloom","year":"1994"},{"key":"10.1016\/j.intimp.2009.04.009_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0171-2985(11)80461-4","article-title":"Prospects for low dose BCG vaccination against tuberculosis","volume":"191","author":"Bretscher","year":"1994","journal-title":"Immunobiology"},{"key":"10.1016\/j.intimp.2009.04.009_bib4","series-title":"Concepts in vaccine development","first-page":"187","article-title":"Quantitative considerations in the design of vaccination strategies against pathogens uniquely susceptible to cell-mediated attack","author":"Bretscher","year":"1996"},{"issue":"3","key":"10.1016\/j.intimp.2009.04.009_bib5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/314072","article-title":"Preventing tuberculosis with Bacillus Calmette\u2013Guerin vaccine: a meta-analysis of the literature","volume":"31","author":"Brewer","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.intimp.2009.04.009_bib6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0264-410X(94)00055-R","article-title":"Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG","volume":"13","author":"Buddle","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2009.04.009_bib7","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.271.9.698","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2009.04.009_bib8","first-page":"163","article-title":"Studies on the quality control of BCG vaccine: laboratory examinations and post vaccination control in the field","volume":"58","author":"Engibarov","year":"1986","journal-title":"Dev Biol Stand"},{"issue":"3","key":"10.1016\/j.intimp.2009.04.009_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1165\/ajrcmb.22.3.3776","article-title":"Pulmonary immune responses during primary Mycobacterium bovis\u2013Calmette\u2013Guerin bacillus infection in C57Bl\/6 mice","volume":"22","author":"Fulton","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.intimp.2009.04.009_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1054\/tuld.1998.0202","article-title":"Vaccine protocols to optimize the protective efficacy of BCG","volume":"79","author":"Griffin","year":"1999","journal-title":"Tuber Lung Dis"},{"issue":"6","key":"10.1016\/j.intimp.2009.04.009_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1054\/tube.2002.0340","article-title":"Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with M. tuberculosis","volume":"82","author":"Gruppo","year":"2002","journal-title":"Tuberculosis"},{"issue":"4","key":"10.1016\/j.intimp.2009.04.009_bib12","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.vaccine.2005.08.001","article-title":"Extraordinary few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity","volume":"24","author":"Horwitz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2009.04.009_bib13","first-page":"435","article-title":"Tuberculin sensitivity in guinea-pigs after vaccination with varying doses of BCG of 12 different strains","volume":"53","author":"Ladefoged","year":"1976","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.intimp.2009.04.009_bib14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/iai.28.2.508-515.1980","article-title":"Macrophage activation and resistance to pulmonary tuberculosis","volume":"28","author":"Lefford","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2009.04.009_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.0300-9475.2004.01471.x","article-title":"The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis","volume":"60","author":"Olsen","year":"2004","journal-title":"Scand J Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2009.04.009_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1165\/ajrcmb\/3.2.131","article-title":"Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans?","volume":"3","author":"Pabst","year":"1990","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.intimp.2009.04.009_bib17","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1128\/IAI.70.3.1410-1416.2002","article-title":"Lymphocyte recruitment and protective efficacy against pulmonary mycobacterial infection are independent of the route of prior Mycobacterium bovis BCG immunization","volume":"70","author":"Palendira","year":"2002","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.intimp.2009.04.009_bib18","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1128\/IAI.66.12.5743-5750.1998","article-title":"Mycobacterial dose defines the Th1\/Th2 nature of immune response independently of whether immunization is administered by the intravenous, subcutaneous or intradermal route","volume":"66","author":"Power","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.intimp.2009.04.009_bib19","first-page":"115","article-title":"Experimental studies on immunizing properties of low doses BCG vaccine","volume":"3","author":"Rodopska","year":"1956","journal-title":"Book NIEM"},{"key":"10.1016\/j.intimp.2009.04.009_bib20","first-page":"283","article-title":"Quantitative evaluation of the effectiveness of Connaught freeze-dried BCG vaccine in mice and in guinea pigs","volume":"51","author":"Siebenmann","year":"1974","journal-title":"Bull World Health Organ"},{"issue":"3","key":"10.1016\/j.intimp.2009.04.009_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1086\/314071","article-title":"Animal models for experimental tuberculosis","volume":"31","author":"Smith","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.intimp.2009.04.009_bib22","unstructured":"World Health Organization; 1977; In vitro assays of BCG products \/TB\/Tech.Guide\/77.9\/."},{"key":"10.1016\/j.intimp.2009.04.009_bib23","unstructured":"World Health Organization; 1987; Expert Committee on Biological Standardization; Technical Report Series 745."},{"key":"10.1016\/j.intimp.2009.04.009_bib24","series-title":"Consultation on the characterization of BCG vaccines","author":"World Health Organization","year":"2004"},{"issue":"10","key":"10.1016\/j.intimp.2009.04.009_bib25","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1084\/jem.20010685","article-title":"Lymphocyte homing to Bronchus-Associated Lymphoid Tissue (BALT) is mediated by L-selectin\/PNAd, \u03b14\u03b21 integrin\/VCAM-1 and LFA-1 adhesion pathways","volume":"197","author":"Xu","year":"2003","journal-title":"J Exp Med"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757690900157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757690900157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T11:41:28Z","timestamp":1633347688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757690900157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":25,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S156757690900157X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2009.04.009","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}